Fernando Perez-Ruiz Selected Research

Therapeutics

1/2023	Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set.
1/2022	One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study.
11/2020	Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
1/2019	Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.
1/2019	Combination urate-lowering therapy in the treatment of gout: What is the evidence?
1/2019	Gout.
1/2018	Improving adherence to gout therapy: an expert review.
1/2018	Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study.
12/2017	Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort.
1/2017	Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando Perez-Ruiz Research Topics

Disease

53	Gout 01/2023 - 08/2002
9	Inflammation (Inflammations) 12/2017 - 01/2009
7	Hyperuricemia 12/2016 - 01/2008
5	Pain (Aches) 01/2022 - 10/2009
5	Gouty Arthritis 11/2019 - 10/2006
3	Arthritis (Polyarthritis) 10/2023 - 11/2012
3	Arthralgia (Joint Pain) 10/2023 - 06/2016
3	Hyperlipidemias (Hyperlipidemia) 12/2020 - 09/2015
3	Hypertension (High Blood Pressure) 12/2020 - 09/2015
3	Rheumatic Diseases (Rheumatism) 12/2016 - 10/2015
2	Lithiasis 03/2019 - 09/2010
2	Renal Insufficiency (Renal Failure) 03/2019 - 06/2016
2	Chronic Disease (Chronic Diseases) 01/2019 - 01/2018
2	Chronic Renal Insufficiency 12/2017 - 01/2016
2	Rheumatoid Arthritis 10/2017 - 08/2003
1	Crystal Arthropathies 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Acute Coronary Syndrome 11/2020
1	Stroke (Strokes) 11/2020
1	Myocardial Infarction 11/2020
1	Dementia (Dementias) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 12/2017
1	Headache (Headaches) 06/2016
1	Nasopharyngitis 06/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2016
1	Kidney Diseases (Kidney Disease) 03/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2016
1	Malnutrition (Nutritional Deficiencies) 12/2015
1	Growth Disorders 12/2015
1	Thyroid Diseases (Thyroid Disease) 11/2015
1	Erythema 09/2015
1	Mobility Limitation (Difficulty Walking) 09/2015
1	Cysts 09/2015
1	Insulin Resistance 09/2015
1	Neoplasms (Cancer) 12/2012
1	Weight Loss (Weight Reduction) 12/2011
1	Low Back Pain (Lumbago) 12/2010
1	Renal Colic 09/2010

Drug/Important Bio-Agent (IBA)

52	Uric Acid (Urate)IBA 01/2023 - 08/2002
8	Allopurinol (Remid)FDA LinkGeneric 01/2022 - 09/2010
8	Febuxostat FDA Link 11/2020 - 06/2009
6	Colchicine FDA LinkGeneric 01/2022 - 06/2009
5	lesinuradIBA 03/2019 - 06/2016
5	Xanthine OxidaseIBA 01/2019 - 08/2010
4	Calcium PyrophosphateIBA 10/2023 - 03/2007
3	CreatinineIBA 01/2020 - 06/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 06/2009
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 06/2009
3	DiureticsIBA 12/2017 - 12/2011
3	SugarsIBA 01/2017 - 03/2016
3	Pegloticase FDA Link 11/2012 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2016
2	Xanthine DehydrogenaseIBA 11/2015 - 03/2015
2	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2013 - 06/2009
1	2-(2,6-dioxopiperidin-3-yl)phthalimidine (EM 12)IBA 01/2019
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2019
1	InflammasomesIBA 01/2019
1	BenzbromaroneIBA 12/2018
1	Probenecid (Benemid)FDA LinkGeneric 12/2018
1	dimemorfan (AT 17)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 12/2017
1	Biosimilar PharmaceuticalsIBA 10/2017
1	ABP 501IBA 10/2017
1	Adalimumab (Humira)FDA Link 10/2017
1	Methotrexate (Mexate)FDA LinkGeneric 10/2017
1	antineoplaston A10 (A 10)IBA 01/2016
1	SmokeIBA 12/2015
1	Trichloroethylene (Trichloroethene)IBA 12/2015
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2015
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2015
1	SodiumIBA 09/2015
1	Uricosuric AgentsIBA 03/2015
1	Free RadicalsIBA 11/2014
1	Interleukin-1 (Interleukin 1)IBA 03/2014
1	TabletsIBA 03/2014
1	rilonacept FDA Link 03/2014
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2014
1	canakinumab FDA Link 03/2014
1	Indomethacin (Indometacin)FDA LinkGeneric 09/2012
1	Analgesics (Analgesic Drugs)IBA 09/2012
1	Celecoxib (Celebrex)FDA Link 09/2012
1	Losartan (Cozaar)FDA LinkGeneric 12/2011
1	Fenofibrate (CiL)FDA LinkGeneric 12/2011
1	Leflunomide (Arava)FDA LinkGeneric 08/2003
1	Phosphates (Orthophosphate)IBA 08/2003
1	benzbromarone drug combination allopurinolIBA 08/2002

Therapy/Procedure

20	Therapeutics 01/2023 - 08/2002
2	Drug Therapy (Chemotherapy) 12/2018 - 01/2018
1	Biological Therapy 01/2019
1	Bariatric Surgery 11/2017
1	Aftercare (After-Treatment) 03/2017
1	Ambulatory Care (Outpatient Care) 12/2012